RA Capital Management »

Galecto shares owned by RA Capital Management

Quarter-by-quarter ownership of Galecto (DMRA) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Galecto

Tip: Access up to 7 years of quarterly data

All positions including Galecto held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galecto by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $62M 2.4M 25.90

More positions owned by RA Capital Management

Ascendis Pharma A/s - Sponsored Adr (ASND)
Vaxcyte Common Stock (PCVX)
Rhythm Pharmaceuticals Common Stock (RYTM)
Tyra Biosciences Common Stock (TYRA)
Sionna Therapeutics Common Stock (SION)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Nuvalent Inc-a Common Stock (NUVL)
Dianthus Therapeutics Common Stock (DNTH)
Mineralys Therapeutics Common Stock (MLYS)
Spyglass Pharma Common Stock
Wave Life Sciences Common Stock (WVE)
Septerna Common Stock (SEPN)
Disc Medicine Common Stock (IRON)
Janux Therapeutics Common Stock (JANX)

View all positions for RA Capital Management

Top funds holding Galecto

Fairmount Funds Management
VR Adviser
RA Capital Management
Henderson Group
Viking Global Investors
Remedium Capital Partners
Commodore Capital
Cormorant Asset Management
Balyasny Asset Management
AH Capital Management
Perceptive Advisors
Point72 Asset Management
Braidwell
Vestal Point Capital
Blackstone Group

View all funds holding Galecto